MOF phosphorylation by ATM regulates 53BP1-mediated double-strand break repair pathway choice.

TitleMOF phosphorylation by ATM regulates 53BP1-mediated double-strand break repair pathway choice.
Publication TypeJournal Article
Year of Publication2014
AuthorsGupta A, Hunt CR, Hegde ML, Chakraborty S, Chakraborty S, Udayakumar D, Horikoshi N, Singh M, Ramnarain DB, Hittelman WN, Namjoshi S, Asaithamby A, Hazra TK, Ludwig T, Pandita RK, Tyler JK, Pandita TK
JournalCell Rep
Volume8
Issue1
Pagination177-89
Date Published2014 Jul 10
ISSN2211-1247
KeywordsAnimals, Ataxia Telangiectasia Mutated Proteins, BRCA1 Protein, Cell Line, Tumor, DNA Breaks, Double-Stranded, G1 Phase Cell Cycle Checkpoints, G2 Phase Cell Cycle Checkpoints, HEK293 Cells, Histone Acetyltransferases, Humans, Intracellular Signaling Peptides and Proteins, Mice, Mutation, Phosphorylation, Recombinational DNA Repair, Tumor Suppressor p53-Binding Protein 1
Abstract

Cell-cycle phase is a critical determinant of the choice between DNA damage repair by nonhomologous end-joining (NHEJ) or homologous recombination (HR). Here, we report that double-strand breaks (DSBs) induce ATM-dependent MOF (a histone H4 acetyl-transferase) phosphorylation (p-T392-MOF) and that phosphorylated MOF colocalizes with γ-H2AX, ATM, and 53BP1 foci. Mutation of the phosphorylation site (MOF-T392A) impedes DNA repair in S and G2 phase but not G1 phase cells. Expression of MOF-T392A also blocks the reduction in DSB-associated 53BP1 seen in wild-type S/G2 phase cells, resulting in enhanced 53BP1 and reduced BRCA1 association. Decreased BRCA1 levels at DSB sites correlates with defective repairosome formation, reduced HR repair, and decreased cell survival following irradiation. These data support a model whereby ATM-mediated MOF-T392 phosphorylation modulates 53BP1 function to facilitate the subsequent recruitment of HR repair proteins, uncovering a regulatory role for MOF in DSB repair pathway choice during S/G2 phase.

DOI10.1016/j.celrep.2014.05.044
Alternate JournalCell Rep
PubMed ID24953651
PubMed Central IDPMC4300955
Grant ListCA154320 / CA / NCI NIH HHS / United States
CA129537 / CA / NCI NIH HHS / United States
Related Faculty: 
Jessica K. Tyler, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700